$2.94 Billion is the total value of Cormorant Asset Management, LP's 104 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 38.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $236,950,000 | -8.9% | 3,037,042 | +10.4% | 8.05% | +38.9% |
| IWM | Sell | ISHARES TRput | $229,370,000 | -48.1% | 1,000,000 | -50.0% | 7.79% | -20.8% |
| AVIR | ATEA PHARMACEUTICALS INC | $137,716,000 | -65.2% | 6,411,355 | 0.0% | 4.68% | -47.0% | |
| FMTX | Buy | FORMA THERAPEUTICS HLDGS INC | $117,520,000 | -11.1% | 4,721,589 | +0.0% | 3.99% | +35.5% |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $114,665,000 | -14.2% | 1,880,980 | -13.3% | 3.90% | +30.9% |
| DSGN | Buy | DESIGN THERAPEUTICS INC | $105,965,000 | -27.6% | 5,414,850 | +5.9% | 3.60% | +10.4% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $105,953,000 | -8.5% | 3,338,166 | +32.2% | 3.60% | +39.4% |
| OLMA | Sell | OLEMA PHARMACEUTICALS INC | $85,996,000 | -18.2% | 3,073,485 | -3.8% | 2.92% | +24.8% |
| BCAB | Sell | BIOATLA INC | $82,714,000 | -24.8% | 1,951,718 | -11.0% | 2.81% | +14.7% |
| GLUE | New | MONTE ROSA THERAPEUTICS INC | $69,550,000 | – | 3,193,973 | +100.0% | 2.36% | – |
| ARKG | New | ARK ETF TRput | $69,375,000 | – | 750,000 | +100.0% | 2.36% | – |
| EWTX | Buy | EDGEWISE THERAPEUTICS INC | $66,530,000 | -10.5% | 3,140,914 | +34.2% | 2.26% | +36.6% |
| ARKK | New | ARK ETF TRput | $65,390,000 | – | 500,000 | +100.0% | 2.22% | – |
| RNA | Sell | AVIDITY BIOSCIENCES INC | $55,070,000 | +2.5% | 2,228,667 | -9.6% | 1.87% | +56.2% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $53,720,000 | -32.9% | 850,000 | -54.5% | 1.82% | +2.3% |
| ALXO | Buy | ALX ONCOLOGY HLDGS INC | $48,635,000 | -25.2% | 889,454 | +0.9% | 1.65% | +14.0% |
| BMEA | New | BIOMEA FUSION INC | $48,434,000 | – | 3,170,872 | +100.0% | 1.64% | – |
| AMAM | New | AMBRX BIOPHARMA INCsponsored ads | $47,032,000 | – | 2,486,386 | +100.0% | 1.60% | – |
| ZYME | Sell | ZYMEWORKS INC | $45,858,000 | -27.4% | 1,321,936 | -33.9% | 1.56% | +10.7% |
| AVTE | New | AEROVATE THERAPEUTICS INC | $44,613,000 | – | 2,030,691 | +100.0% | 1.52% | – |
| RXDX | Sell | PROMETHEUS BIOSCIENCES INC | $44,480,000 | +21.5% | 1,848,024 | -11.9% | 1.51% | +85.2% |
| TARS | Sell | TARSUS PHARMACEUTICALS INC | $43,884,000 | -20.6% | 1,514,269 | -11.7% | 1.49% | +21.1% |
| STOK | Sell | STOKE THERAPEUTICS INC | $43,027,000 | -23.0% | 1,278,276 | -11.1% | 1.46% | +17.5% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $42,897,000 | -29.4% | 968,550 | -29.2% | 1.46% | +7.7% |
| VERV | New | VERVE THERAPEUTICS INC | $40,594,000 | – | 709,224 | +100.0% | 1.38% | – |
| RAIN | New | RAIN THERAPEUTICS INC | $39,734,000 | – | 2,626,660 | +100.0% | 1.35% | – |
| ACRS | ACLARIS THERAPEUTICS INC | $35,120,000 | -30.3% | 2,000,000 | 0.0% | 1.19% | +6.2% | |
| CNTA | New | CENTESSA PHARMACEUTICALS PLCsponsored ads | $31,054,000 | – | 1,427,273 | +100.0% | 1.06% | – |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $28,268,000 | -40.0% | 175,000 | -36.4% | 0.96% | -8.5% |
| YMAB | Sell | Y-MABS THERAPEUTICS INC | $27,040,000 | -27.3% | 800,000 | -35.0% | 0.92% | +10.9% |
| AGEN | Sell | AGENUS INC | $26,393,000 | +25.2% | 4,807,557 | -38.0% | 0.90% | +90.9% |
| ELEV | New | ELEVATION ONCOLOGY INC | $25,566,000 | – | 1,983,165 | +100.0% | 0.87% | – |
| VECT | New | VECTIVBIO HLDG AG | $25,531,000 | – | 2,226,128 | +100.0% | 0.87% | – |
| TWST | TWIST BIOSCIENCE CORP | $24,651,000 | +7.6% | 185,000 | 0.0% | 0.84% | +64.1% | |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $23,798,000 | -40.3% | 168,150 | -58.0% | 0.81% | -9.0% |
| XLRN | Sell | ACCELERON PHARMA INC | $21,961,000 | -41.1% | 175,000 | -36.4% | 0.75% | -10.2% |
| MASS | Sell | 908 DEVICES INC | $21,131,000 | -18.5% | 545,320 | -0.0% | 0.72% | +24.4% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $20,895,000 | -13.1% | 237,546 | -3.9% | 0.71% | +32.7% |
| LBPH | Sell | LONGBOARD PHARMACEUTICALS IN | $20,869,000 | -43.9% | 2,321,403 | -1.5% | 0.71% | -14.5% |
| IGMS | Sell | IGM BIOSCIENCES INC | $20,800,000 | -45.3% | 250,000 | -49.6% | 0.71% | -16.5% |
| AXNX | Sell | AXONICS INC | $20,433,000 | -50.8% | 322,240 | -53.5% | 0.69% | -25.0% |
| PRAX | Sell | PRAXIS PRECISION MEDICINES I | $18,721,000 | -46.8% | 1,024,145 | -4.7% | 0.64% | -18.9% |
| Sell | DERMTECH INC | $18,706,000 | -54.0% | 450,000 | -43.8% | 0.64% | -29.8% | |
| ALGS | Sell | ALIGOS THERAPEUTICS INC | $18,458,000 | -35.9% | 905,467 | -28.5% | 0.63% | -2.3% |
| OMER | Sell | OMEROS CORP | $17,808,000 | -69.7% | 1,200,000 | -63.6% | 0.60% | -53.8% |
| TALS | New | TALARIS THERAPEUTICS INC | $17,264,000 | – | 1,215,847 | +100.0% | 0.59% | – |
| AKRO | Sell | AKERO THERAPEUTICS INC | $14,886,000 | -30.9% | 600,000 | -19.2% | 0.51% | +5.4% |
| OMER | OMEROS CORPcall | $14,840,000 | -16.6% | 1,000,000 | 0.0% | 0.50% | +27.0% | |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $14,048,000 | -41.6% | 482,413 | -21.1% | 0.48% | -11.0% |
| CABA | Sell | CABALETTA BIO INC | $13,860,000 | -34.4% | 1,611,623 | -15.4% | 0.47% | 0.0% |
| PHVS | Sell | PHARVARIS N V | $13,634,000 | -42.7% | 744,863 | -13.8% | 0.46% | -12.6% |
| CCCC | Sell | C4 THERAPEUTICS INC | $13,414,000 | -85.4% | 354,495 | -85.8% | 0.46% | -77.8% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $12,871,000 | -6.4% | 100,000 | -41.8% | 0.44% | +42.8% |
| CNTB | Sell | CONNECT BIOPHARMA HLDGS LTDads | $12,694,000 | -31.4% | 650,000 | -35.0% | 0.43% | +4.6% |
| Sell | APTOSE BIOSCIENCES INC | $12,640,000 | -47.1% | 3,807,200 | -4.8% | 0.43% | -19.4% | |
| GHRS | New | GH RESEARCH PLCordinary shares | $12,554,000 | – | 608,123 | +100.0% | 0.43% | – |
| MYOV | Sell | MYOVANT SCIENCES LTD | $12,353,000 | -40.0% | 542,499 | -45.8% | 0.42% | -8.3% |
| RPTX | Sell | REPARE THERAPEUTICS INC | $11,342,000 | -20.0% | 363,766 | -21.3% | 0.38% | +21.8% |
| ELDN | ELEDON PHARMACEUTICALS INC | $11,197,000 | -26.1% | 1,415,500 | 0.0% | 0.38% | +12.8% | |
| MORF | Sell | MORPHIC HLDG INC | $10,891,000 | -50.8% | 189,774 | -45.8% | 0.37% | -24.9% |
| HGEN | Sell | HUMANIGEN INC | $10,428,000 | -45.4% | 600,000 | -40.0% | 0.35% | -16.9% |
| ANAB | Sell | ANAPTYSBIO INC | $9,985,000 | -28.7% | 385,081 | -40.8% | 0.34% | +8.7% |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $9,866,000 | -23.4% | 75,000 | -25.0% | 0.34% | +16.7% |
| ZLAB | Sell | ZAI LAB LTDadr | $9,461,000 | -52.7% | 53,455 | -64.4% | 0.32% | -28.0% |
| INSP | Sell | INSPIRE MED SYS INC | $9,302,000 | -47.1% | 48,132 | -43.4% | 0.32% | -19.4% |
| BCTG | BCTG ACQUISITION CORP | $9,096,000 | +2.2% | 800,000 | 0.0% | 0.31% | +56.1% | |
| GLTO | Sell | GALECTO INC | $8,874,000 | -32.1% | 1,753,839 | -18.5% | 0.30% | +3.4% |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $7,869,000 | -60.4% | 479,506 | -46.7% | 0.27% | -39.7% |
| HARP | Sell | HARPOON THERAPEUTICS INC | $7,498,000 | -37.2% | 540,600 | -5.3% | 0.26% | -4.1% |
| New | CATABASIS PHARMACEUTICALS IN | $7,490,000 | – | 3,550,000 | +100.0% | 0.25% | – | |
| SBTX | Sell | SILVERBACK THERAPEUTICS INC | $7,386,000 | -66.1% | 239,099 | -52.2% | 0.25% | -48.4% |
| QURE | Sell | UNIQURE NV | $7,378,000 | -12.4% | 239,548 | -4.2% | 0.25% | +33.5% |
| ITOS | Sell | ITEOS THERAPEUTICS INC | $7,396,000 | -27.9% | 288,330 | -3.9% | 0.25% | +10.1% |
| INSM | Sell | INSMED INC | $7,115,000 | -30.4% | 250,000 | -16.7% | 0.24% | +6.1% |
| VERU | Sell | VERU INC | $6,456,000 | -80.0% | 800,000 | -73.3% | 0.22% | -69.6% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $6,273,000 | -18.2% | 342,962 | -25.3% | 0.21% | +24.6% |
| MRUS | Sell | MERUS N V | $6,007,000 | -17.8% | 285,096 | -18.5% | 0.20% | +25.2% |
| GRPH | New | GRAPHITE BIO INC | $5,931,000 | – | 203,153 | +100.0% | 0.20% | – |
| AVEO | Sell | AVEO PHARMACEUTICALS INC | $5,888,000 | -46.4% | 893,500 | -40.4% | 0.20% | -18.4% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $5,288,000 | -41.0% | 144,439 | -27.8% | 0.18% | -10.0% |
| AKUS | Sell | AKOUOS INC | $4,951,000 | -28.6% | 394,500 | -21.1% | 0.17% | +9.1% |
| SRNE | Sell | SORRENTO THERAPEUTICS INC | $4,845,000 | -78.7% | 500,000 | -81.8% | 0.16% | -67.5% |
| MGTA | Sell | MAGENTA THERAPEUTICS INC | $4,677,000 | -34.2% | 478,200 | -20.3% | 0.16% | +0.6% |
| HLXA | HELIX ACQUISITION CORP | $4,450,000 | +1.5% | 430,000 | 0.0% | 0.15% | +54.1% | |
| QTNT | Sell | QUOTIENT LTD | $4,380,000 | -20.7% | 1,203,328 | -19.8% | 0.15% | +21.1% |
| TBPH | Sell | THERAVANCE BIOPHARMA INC | $4,356,000 | -61.2% | 300,000 | -45.5% | 0.15% | -40.8% |
| DTIL | PRECISION BIOSCIENCES INC | $4,338,000 | +20.9% | 346,524 | 0.0% | 0.15% | +83.8% | |
| FVAM | Sell | 5 01 ACQUISITION CORP | $3,988,000 | -20.0% | 400,000 | -20.0% | 0.14% | +21.6% |
| GTH | Sell | GENETRON HLDGS LTDads | $2,676,000 | -58.4% | 132,867 | -55.7% | 0.09% | -36.4% |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCspon ads | $2,604,000 | +7.6% | 392,167 | -7.1% | 0.09% | +63.0% |
| HSAQ | Sell | HEALTH SCIENCES ACQ CORP 2 | $2,448,000 | -72.8% | 240,000 | -70.0% | 0.08% | -58.5% |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $2,428,000 | -31.4% | 284,988 | -28.8% | 0.08% | +3.8% |
| BCEL | Sell | ATRECA INC | $2,330,000 | -48.2% | 273,500 | -6.8% | 0.08% | -21.0% |
| TCDA | TRICIDA INC | $1,849,000 | -18.3% | 427,975 | 0.0% | 0.06% | +26.0% | |
| GOSS | Sell | GOSSAMER BIO INC | $1,611,000 | -79.5% | 198,382 | -76.6% | 0.06% | -68.6% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $1,236,000 | -86.6% | 15,000 | -88.0% | 0.04% | -79.5% |
| ORTX | ORCHARD THERAPEUTICS PLCads | $1,127,000 | -39.5% | 256,649 | 0.0% | 0.04% | -9.5% | |
| XFOR | X4 PHARMACEUTICALS INC | $676,000 | -24.5% | 103,980 | 0.0% | 0.02% | +15.0% | |
| CRDF | Sell | CARDIFF ONCOLOGY INC | $637,000 | -54.1% | 95,720 | -36.2% | 0.02% | -29.0% |
| NERV | Buy | MINERVA NEUROSCIENCES INC | $570,000 | -2.4% | 245,744 | +22.9% | 0.02% | +46.2% |
| IMV | IMV INC | $507,000 | -34.3% | 234,374 | 0.0% | 0.02% | 0.0% | |
| CEREW | Sell | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $278,000 | -50.6% | 19,316 | -85.5% | 0.01% | -30.8% |
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $217,000 | -2.3% | 83,332 | 0.0% | 0.01% | +40.0% | |
| OTLKW | OUTLOOK THERAPEUTICS INC*w exp 02/18/202 | $130,000 | -69.1% | 416,666 | 0.0% | 0.00% | -55.6% | |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -20,000 | -100.0% | -0.01% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -10,000 | -100.0% | -0.02% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -20,000 | -100.0% | -0.03% | – |
| GRCL | Exit | GRACELL BIOTECHNOLOGIES INCsponsored ads | $0 | – | -125,000 | -100.0% | -0.04% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -130,000 | -100.0% | -0.05% | – |
| NUVB | Exit | NUVATION BIO INC | $0 | – | -234,445 | -100.0% | -0.06% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -25,000 | -100.0% | -0.06% | – |
| KDMN | Exit | KADMON HLDGS INC | $0 | – | -750,000 | -100.0% | -0.06% | – |
| TIL | Exit | INSTIL BIO INC | $0 | – | -150,000 | -100.0% | -0.08% | – |
| REPL | Exit | REPLIMUNE GROUP INC | $0 | – | -125,000 | -100.0% | -0.08% | – |
| VSPRU | Exit | VESPER HEALTHCARE ACQSTN CORunit 99/99/9999 | $0 | – | -400,000 | -100.0% | -0.10% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -70,000 | -100.0% | -0.12% | – |
| RACA | Exit | THERAPEUTICS ACQUISITION COR | $0 | – | -500,000 | -100.0% | -0.12% | – |
| BLSA | Exit | BCLS ACQUISITION CORP | $0 | – | -500,000 | -100.0% | -0.12% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -337,048 | -100.0% | -0.12% | – |
| TARA | Exit | PROTARA THERAPEUTICS INC | $0 | – | -350,000 | -100.0% | -0.12% | – |
| CGEM | Exit | CULLINAN ONCOLOGY INC | $0 | – | -150,000 | -100.0% | -0.14% | – |
| GMTX | Exit | GEMINI THERAPEUTICS INC | $0 | – | -475,000 | -100.0% | -0.14% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -30,000 | -100.0% | -0.18% | – |
| FDMT | Exit | 4D MOLECULAR THERAPEUTICS IN | $0 | – | -200,000 | -100.0% | -0.19% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -100,000 | -100.0% | -0.24% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -200,000 | -100.0% | -0.25% | – |
| FHTX | Exit | FOGHORN THERAPEUTICS INC | $0 | – | -1,000,000 | -100.0% | -0.29% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -200,000 | -100.0% | -0.30% | – |
| ALBO | Exit | ALBIREO PHARMA INC | $0 | – | -500,000 | -100.0% | -0.39% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -750,000 | -100.0% | -0.43% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INCput | $0 | – | -300,000 | -100.0% | -0.54% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -850,000 | -100.0% | -0.97% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -250,000 | -100.0% | -1.01% | – |
| XBI | Exit | SPDR SER TRput | $0 | – | -1,000,000 | -100.0% | -3.02% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -1,000,000 | -100.0% | -8.83% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QUOTIENT LTD | 30 | Q3 2021 | 4.3% |
| ASCENDIS PHARMA A/S | 30 | Q4 2022 | 4.8% |
| MINERVA NEUROSCIENCES INC | 29 | Q3 2021 | 4.4% |
| ACCELERON PHARMA INC | 28 | Q2 2021 | 3.4% |
| OMEROS CORP | 27 | Q3 2021 | 6.5% |
| MIRATI THERAPEUTICS INC | 25 | Q4 2022 | 7.6% |
| BLUEPRINT MEDICINES CORP | 25 | Q3 2021 | 3.6% |
| APELLIS PHARMACEUTICALS INC | 24 | Q3 2023 | 8.6% |
| NEUROCRINE BIOSCIENCES INC | 24 | Q1 2020 | 4.6% |
| ROCKET PHARMACEUTICALS, INC | 23 | Q3 2023 | 2.4% |
View Cormorant Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ambrx Biopharma Inc. | March 13, 2023 | 42,771,365 | - |
| Altimmune, Inc. | February 14, 2023 | 2,600,000 | - |
| Arcellx, Inc. | February 14, 2023 | 2,075,000 | - |
| BioAtla, Inc. | February 14, 2023 | 2,499,250 | - |
| Eledon Pharmaceuticals, Inc. | February 14, 2023 | 1,391,663 | - |
| GreenLight Biosciences Holdings, PBC | February 14, 2023 | 4,751,020 | - |
| Prometheus Biosciences, Inc. | February 14, 2023 | 700,000 | - |
| Tango Therapeutics, Inc. | February 14, 2023 | 1,000,000 | - |
| VectivBio Holding AG | February 14, 2023 | 1,515,087 | - |
| Viridian Therapeutics, Inc.\DE | February 14, 2023 | 1,100,000 | - |
View Cormorant Asset Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-22 |
| SC 13G/A | 2024-04-15 |
| 4 | 2024-04-03 |
| SC 13G | 2024-03-21 |
| 4 | 2024-03-18 |
| SC 13G/A | 2024-03-18 |
| 4 | 2024-03-11 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Cormorant Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.